Remdesivir for 5 or 10 Days in Patients with Severe Covid-19.

Abstract Background Remdesivir is an RNA polymerase inhibitor with potent antiviral activity in vitro and efficacy in animal models of coronavirus disease 2019 (Covid-19). Methods We conducted a ra...